Glenmark Life Sciences Limited (IN:ALIVUS)
:ALIVUS
Want to see IN:ALIVUS full AI Analyst Report?
Summary of all the Indicators
Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Glenmark Life Sciences Limited’s (ALIVUS) Moving Averages Convergence Divergence (MACD) indicator is 5.05, suggesting Glenmark Life Sciences Limited is a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) 20-Day exponential moving average is 1059.70, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Sell.
Glenmark Life Sciences Limited’s (ALIVUS) 50-Day exponential moving average is 1029.63, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited (ALIVUS) Pivot Points
Classic
990.08
1,010.82
1,023.38
1,044.12
1,056.68
1,077.42
1,089.98
Fibonacci
1,010.82
1,023.54
1,031.40
1,044.12
1,056.84
1,064.70
1,077.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Glenmark Life Sciences Limited (ALIVUS) Moving Averages
MA5
1,051.99Sell
1,050.91Sell
MA10
1,060.35Sell
1,058.65Sell
MA20
1,066.72Sell
1,059.70Sell
MA50
1,026.55Buy
1,029.63Buy
MA100
967.16Buy
994.51Buy
MA200
948.05Buy
979.75Buy
Glenmark Life Sciences Limited’s (ALIVUS) 10-Day exponential moving average is 1058.65, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Sell.
Glenmark Life Sciences Limited’s (ALIVUS) 100-Day exponential moving average is 994.51, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 50-day simple moving average is 1026.55, creating a Buy signal.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 100-day simple moving average is 967.16, creating a Buy signal.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 200-day simple moving average is 948.05, creating a Buy signal.
Glenmark Life Sciences Limited (ALIVUS) Technical Indicators
RSI (14)
48.15
Neutral
STOCH (9,6)
24.02
Neutral
STOCHRSI (14)
19.92
Buy
MACD (12,26)
5.05
Buy
ADX (14)
21.82
Neutral
Williams %R
-78.94
Buy
CCI (14)
-51.84
Neutral
ATR (14)
36.08
-
Ultimate Oscillator
39.87
Neutral
ROC
-2.48
Sell
Glenmark Life Sciences Limited’s (ALIVUS) Relative Strength Index (RSI) is 48.15, creating a Neutral signal.
Glenmark Life Sciences Limited’s (ALIVUS) Trend Strength Indicator (ADX) is 21.82, creating a Neutral signal.
Glenmark Life Sciences Limited’s (ALIVUS) Commodity Channel Index (CCI) is -51.84, creating a Neutral signal.
Glenmark Life Sciences Limited’s (ALIVUS) Price Rate of Change (ROC) is -2.48, creating a Sell signal.
FAQ
Is ALIVUS a Buy, Hold, or Sell?
Based on ALIVUS’s technical indicators, ALIVUS is a Hold.
What is ALIVUS’s RSI (14)?
ALIVUS’s RSI (14) is 48.15, which suggests ALIVUS is a Neutral.
What is ALIVUS’s MACD?
ALIVUS’s MACD is 5.05, which suggests ALIVUS is a Buy.
What is ALIVUS’s 5-day moving average?
ALIVUS’s 5-day moving average is 1051.99, which suggests ALIVUS is a Sell.
What is ALIVUS’s 20-day moving average?
ALIVUS 20-day moving average is 1066.72, which suggests ALIVUS is a Sell.
What is ALIVUS’s 50-day moving average?
ALIVUS’s 50-day moving average is 1026.55, which suggests ALIVUS is a Buy.
What is ALIVUS’s 200-day moving average?
ALIVUS’s 200-day moving average is 948.05, which suggests ALIVUS is a Buy.
What is ALIVUS’s Williams % R (14)?
ALIVUS’s Williams % R (14) is -78.94, which suggests ALIVUS is a Buy.
What is ALIVUS’s CCI (14)?
ALIVUS’s CCI (14) is -51.84, which suggests ALIVUS is a Neutral.
What is the share price of Glenmark Life Sciences Limited?